Telemedicine and Medical Cannabis – Progress or Risk?

A Step Forward: Easier Access to Medical Cannabis Since the legal changes in spring 2024, medical cannabis can now be prescribed with significantly…

Read more

Cannabis Research Projects: Driving Evidence-Based Cannabis Regulation in Germany

Cannabis research in Germany: Discover why cannabis studies are crucial, which cities are participating, and how scientific data paves the way for…

Read more

Directional Choice – The Impact of the Federal Election on the Future of Cannabis Regulation

The year 2024 has been a milestone for the cannabis industry in Germany. The removal of medical cannabis from the Narcotics Act and the launch of…

Read more

Green Rush or Consolidation? The German Medical Cannabis Market in Focus

Is Germany's medical cannabis market booming or heading toward consolidation? Discover the latest Cannabis Briefing for insights into the…

Read more

Looking Back on ‘Yes, We Can Cannabizz’ – An Evening Shaping the Future of Medical Cannabis

Cansativa’s "Yes, We Can Cannabizz" event in Berlin brought together industry leaders, medical experts, and patients to discuss the future of…

Read more

Milestones and Future Visions: 100 Editions of the Cannabis Briefing

Research lies at the heart of advancements in cannabis and medical cannabis. Thorough scientific studies not only enhance therapeutic understanding…

Read more

How the 2024 US Elections Could Impact Cannabis Regulation

In today’s Cannabis Briefing, we look beyond our usual scope and explain why the US elections hold international significance, particularly for…

Read more

Cansativa Expert Dialogue: An Interview with Aline Gralke

Last year, Switzerland launched its first pilot projects to study the recreational use of cannabis. In today’s edition of the Cannabis Briefing, we…

Read more

Slow but Steady: Europe’s Evolving Cannabis Landscape

While Germany has taken the bold step of decriminalizing cannabis for recreational purposes, signaling a major shift in European drug policy, its…

Read more

G-BA Decision on Medical Cannabis – A Win for Patients

Excitement is widespread in the medical cannabis community and among patients. On July 18, the Federal Joint Committee (Gemeinsamer Bundesausschuss…

Read more

The Future of Medical Cannabis: A Review after 100 Days of Decriminalization in Germany

It's been 100 days since cannabis was decriminalized in Germany, and the landscape is evolving rapidly. As of this month, cultivation clubs in…

Read more

The Importance of the EU-Monograph on Cannabis Flowers for Patients across Europe

In this edition of our Cannabis Briefing, we explore a development that promises to reshape the landscape of medical cannabis across Europe—not…

Read more

Cansativa Expert Dialogue: An Interview with Melanie Dolfen, Pharmacist and Pioneer in Medicinal Cannabis

In today’s edition of The Cannabis Briefing, we delve deeper into the current challenges and developments in the realm of medicinal cannabis. We had…

Read more

Summer Highlights: Our Recommendations for Cannabis Events to Attend

As summer draws near, the season of events is just beginning. Continuing our tradition from the last two years, this issue highlights a selection of…

Read more

Unpacking the Cannabis Act: Realities and its Limits

Our readers are well-versed in the societal discourse surrounding cannabis and its legal frameworks. The emotional intensity of the debate persists,…

Read more

Cannabis as a “Fair Weather” Topic – Properly Framing Drug Policy

The recently enacted Cannabis Law marks a significant milestone in German drug policy. However, as soon as the law was passed, the focus swiftly…

Read more

Cansativa Expert Dialogue: Growth and Regulation in Germany’s Medical Cannabis Industry

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

Read more

Medical Cannabis in Germany: What Changes, what Stays the Same?

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

Read more

The CanG in the Bundesrat

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

Read more

Insights into Research: Cannabis as a Potential Factor in Endometriosis Therapy

Medical cannabis is often used in patients with pain when other therapy options are no longer effective. This is frequently the case with chronic…

Read more